Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Motor Vehicle Accident”

337 trials

Showing 20 of 337 results

Early research (Phase 1)Study completedNCT00942071
What this trial is testing

Assess the Safety and Immunogenicity of a New Influenza Vaccine Candidate MVA-NP+M1 in Healthy Adults

Who this might be right for
Influenza
University of Oxford 58
Early research (Phase 1)Study completedNCT02376426
What this trial is testing

Evaluate the Safety and Immunogenicity of Heterologous Prime-Boost Ebola Vaccine Regimens in Healthy Participants

Who this might be right for
Healthy
Crucell Holland BV 72
Testing effectiveness (Phase 2)WithdrawnNCT05950776
What this trial is testing

COVID-19 Trial of the Candidate Vaccine MVA-SARS-2-S in Adults

Who this might be right for
Covid19
Universitätsklinikum Hamburg-Eppendorf
Not applicableStudy completedNCT02049710
What this trial is testing

Teen Video Study to Reduce Risky Driving and Sexual Behavior in Adolescents

Who this might be right for
PregnancySexually Transmitted InfectionsAutomobile Accidents
Carnegie Mellon University 1,317
Early research (Phase 1)Study completedNCT00376090
What this trial is testing

Safety of and Immune Response to a Modified Vaccinia Ankara (MVA) HIV Vaccine in HIV Uninfected Adults

Who this might be right for
HIV Infections
U.S. Army Medical Research and Development Command 48
Very early researchStudy completedNCT03277456
What this trial is testing

Determine the Safety and Immunogenicity of the Candidate Influenza Vaccine MVA-NP+M1

Who this might be right for
Human Volunteers
Barinthus Biotherapeutics 6
Testing effectiveness (Phase 2)Study completedNCT03203421
What this trial is testing

A Safety and Efficacy Study of ChAdOx1 LS2 and MVA LS2

Who this might be right for
Malaria
University of Oxford 18
Testing effectiveness (Phase 2)Looking for participantsNCT06513286
What this trial is testing

TherVacB - A Heterologous Protein Prime/MVA Boost Therapeutic Hepatitis B Vaccine Candidate

Who this might be right for
Chronic Hepatitis B
Michael Hoelscher 81
Not applicableStudy completedNCT06107777
What this trial is testing

The Effectiveness of Pharmacopuncture on Psychological Stress

Who this might be right for
Psychological Stress
Jaseng Medical Foundation 50
Early research (Phase 1)Study completedNCT00374998
What this trial is testing

Safety and Immunogenicity Study of the Malaria Vaccines FP9 PP and MVA PP

Who this might be right for
Malaria, FalciparumMalaria
European Vaccine Initiative 35
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07253675
What this trial is testing

Evaluate the Safety and Immunogenicity of the MVA-SIBP Vaccine in the Democratic Republic of the Congo

Who this might be right for
Monkeypox (Mpox)
Shanghai Institute Of Biological Products 180
Testing effectiveness (Phase 2)Study completedNCT02873286
What this trial is testing

RSV-MVA-BN Vaccine Phase II Trial in ≥ 55 Year Old Adults

Who this might be right for
Respiratory Syncytial Virus Infections
Bavarian Nordic 420
Testing effectiveness (Phase 2)Study completedNCT01668537
What this trial is testing

A Phase II Trial to Compare a Liquid-frozen and a Freeze-dried Formulation of IMVAMUNE (MVA-BN®) Smallpox Vaccine in Vaccinia-naïve Healthy Subjects

Who this might be right for
Smallpox
Bavarian Nordic 651
Testing effectiveness (Phase 2)Study completedNCT00133575
What this trial is testing

ACAM 3000 MVA at Harvard Medical School

Who this might be right for
Smallpox
National Institute of Allergy and Infectious Diseases (NIAID) 72
Early research (Phase 1)Study completedNCT00574600
What this trial is testing

Safety of and Immune Response to Two HIV Vaccines: SAAVI DNA-C2 Boosted With SAAVIMVA-C, in HIV-Negative Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 48
Not applicableEnrolling By InvitationNCT06235632
What this trial is testing

Responsible Marijuana Sales Practices to Reduce the Risk of Selling to Intoxicated Customers

Who this might be right for
Alcoholic IntoxicationAutomobile AccidentCannabis
Klein Buendel, Inc. 229
Early research (Phase 1)UnknownNCT04553016
What this trial is testing

Test Three Experimental HIV Vaccines in Healthy Adults.

Who this might be right for
HIV-1-infection
University of Oxford 88
Early research (Phase 1)Study completedNCT04119440
What this trial is testing

Safety and Immunogenicity of the Candidate Vaccine MVA-MERS-S_DF-1 Against MERS

Who this might be right for
MERS (Middle East Respiratory Syndrome)
Universitätsklinikum Hamburg-Eppendorf 145
Early research (Phase 1)Study completedNCT03307915
What this trial is testing

2 Different Regimens of Tetravalent Ad26.Mos4.HIV Prime Followed by Boost With Modified Vaccinia Ankara (MVA)-Mosaic OR Ad26.Mos4.HIV Plus a Combination of Mosaic and Clade C gp140 Protein in Human Immunodeficiency Virus (HIV) Type 1 Infected Adults on Suppressive Antiretroviral Treatment

Who this might be right for
Human Immunodeficiency Virus
Janssen Vaccines & Prevention B.V. 25
Testing effectiveness (Phase 2)Study completedNCT05458024
What this trial is testing

Vitamin D to ENhance TraUma REcovery

Who this might be right for
Musculoskeletal Pain
University of North Carolina, Chapel Hill 71
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation